Search results for: “dermatology”
-
New Drug Clears Atopic Dermatitis in Clinical Trials
Nearly 40 percent of patients with atopic dermatitis saw their disease completely or almost completely cleared with a new drug called dupilumab, according to a Northwestern Medicine clinical trial.
-
Green Elected to German National Academy of Sciences
Kathleen Green, PhD, Joseph L. Mayberry, Sr., Professor of Pathology and Toxicology and professor of Dermatology, has been elected to the German National Academy of Sciences for her scientific achievements.
-
Founders’ Day Welcomes Incoming Medical Students
Members of the Class of 2020 donned their white coats and were welcomed into the medical profession at the 158th Founders’ Day on August 12.
-
Celebrating Feinberg Faculty Honors
Spotlighting some of the many awards and honors recently earned by Feinberg faculty members.
-
Many Top-Selling Sunscreens Don’t Offer Adequate Protection
Forty percent of top-selling sunscreens don’t meet national standards for protection, and consumers are spending up to 3,000 percent more for products that provide equivalent benefit, according to new research.
-
First Week for Northwestern’s New Residents
Northwestern Medicine welcomed more than 150 first-year residents during the week of June 20, with many attending “bootcamp” training sessions.
-
Kundu Named Associate Dean for Admissions
Roopal Kundu, ’01 MD, ’02 GME, associate professor in Dermatology and Medical Education, has been named associate dean for admissions, effective September 1.
-
Mechanism Behind Chronic Fibrosis Discovered
Northwestern Medicine scientists have shown that a molecule called tenascin-C drives the excess scar buildup seen in fibrotic diseases.
-
New Drug Clears Psoriasis in Clinical Trials
Patients with psoriasis saw their disease completely or almost completely cleared with a new drug called ixekizumab in three recent clinical trials led by a Northwestern Medicine investigator
-
Student Analyzes Epidemiology of Rare Skin Disorders
Medical student Derek Hsu studies the incidence and outcomes of rare skin disorders in order to develop predictors of mortality, information that could help clinicians prevent and treat the conditions.
